| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | TBP-class protein binding | 2.34e-05 | 33 | 102 | 4 | GO:0017025 | |
| GeneOntologyCellularComponent | intraciliary transport particle B | 1.37e-04 | 21 | 101 | 3 | GO:0030992 | |
| GeneOntologyCellularComponent | sperm midpiece | 2.61e-04 | 64 | 101 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | intraciliary transport particle | 3.28e-04 | 28 | 101 | 3 | GO:0030990 | |
| GeneOntologyCellularComponent | actin-based cell projection | 4.05e-04 | 278 | 101 | 7 | GO:0098858 | |
| GeneOntologyCellularComponent | sperm flagellum | 6.06e-04 | 214 | 101 | 6 | GO:0036126 | |
| Domain | Rap_GAP | 1.69e-05 | 10 | 99 | 3 | PF02145 | |
| Domain | Rap_GAP_dom | 2.31e-05 | 11 | 99 | 3 | IPR000331 | |
| Domain | RAPGAP | 2.31e-05 | 11 | 99 | 3 | PS50085 | |
| Domain | SPAR_C | 8.32e-05 | 3 | 99 | 2 | PF11881 | |
| Domain | SIPA1L_C | 8.32e-05 | 3 | 99 | 2 | IPR021818 | |
| Domain | Tox-GHH_dom | 1.66e-04 | 4 | 99 | 2 | IPR028916 | |
| Domain | Tox-GHH | 1.66e-04 | 4 | 99 | 2 | PF15636 | |
| Domain | Ten_N | 1.66e-04 | 4 | 99 | 2 | IPR009471 | |
| Domain | Ten_N | 1.66e-04 | 4 | 99 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.66e-04 | 4 | 99 | 2 | PS51361 | |
| Domain | YD | 2.75e-04 | 5 | 99 | 2 | IPR006530 | |
| Domain | EGF_extracell | 2.88e-04 | 60 | 99 | 4 | IPR013111 | |
| Domain | EGF_2 | 2.88e-04 | 60 | 99 | 4 | PF07974 | |
| Pubmed | UBR2 HDAC5 IFT172 FSTL5 NEDD4 YEATS2 TENM4 SETD5 MACF1 SIPA1L2 | 3.53e-07 | 407 | 102 | 10 | 12693553 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TRIO INPPL1 SIPA1L3 TAB3 NEDD4 FSIP2 SLC16A1 AASS SSX2IP MACF1 CRYBG3 SIPA1L2 DNMBP | 1.48e-06 | 861 | 102 | 13 | 36931259 |
| Pubmed | 2.92e-06 | 209 | 102 | 7 | 36779422 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27732084 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23570448 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23977176 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20138207 | ||
| Pubmed | The centriolar satellite protein SSX2IP promotes centrosome maturation. | 8.52e-06 | 2 | 102 | 2 | 23816619 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27061915 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 10444334 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 33075816 | ||
| Pubmed | Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer. | 8.52e-06 | 2 | 102 | 2 | 36221793 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20849853 | ||
| Pubmed | RABL2 positively controls localization of GPCRs in mammalian primary cilia. | 8.52e-06 | 2 | 102 | 2 | 30578315 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRIO MFHAS1 INPPL1 SIPA1L3 PLXNB2 ACOX3 HEG1 SETD5 PLA2G4B NBEAL2 DEPDC5 SIPA1L2 DNMBP | 2.14e-05 | 1105 | 102 | 13 | 35748872 |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 28585553 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 38200519 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 28236338 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 25663546 | ||
| Pubmed | RapGAPs in brain: multipurpose players in neuronal Rap signalling. | 2.55e-05 | 3 | 102 | 2 | 20576033 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19574399 | ||
| Pubmed | HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. | 2.55e-05 | 3 | 102 | 2 | 17438519 | |
| Pubmed | The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells. | 2.55e-05 | 3 | 102 | 2 | 29455656 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 28380328 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 5.09e-05 | 4 | 102 | 2 | 10225957 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 17426452 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 8912867 | ||
| Pubmed | SOX10 is a novel oncogene in hepatocellular carcinoma through Wnt/β-catenin/TCF4 cascade. | 5.09e-05 | 4 | 102 | 2 | 25001176 | |
| Pubmed | ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases. | 5.09e-05 | 4 | 102 | 2 | 17085477 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 5.09e-05 | 4 | 102 | 2 | 12000766 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 11567631 | ||
| Pubmed | UBR2 MYO1D TRIO SIPA1L3 DHX38 POR DDOST TAB3 SORT1 PTPRZ1 SSX2IP CRYBG3 | 5.95e-05 | 1049 | 102 | 12 | 27880917 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 6.03e-05 | 588 | 102 | 9 | 38580884 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 2895697 | ||
| Pubmed | Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program. | 8.47e-05 | 5 | 102 | 2 | 30118678 | |
| Pubmed | Rabl2 GTP hydrolysis licenses BBSome-mediated export to fine-tune ciliary signaling. | 8.47e-05 | 5 | 102 | 2 | 33241915 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 19893013 | ||
| Pubmed | Mapping the gene for LTW-4, a 26,000 molecular weight major protein of mouse liver and kidney. | 8.47e-05 | 5 | 102 | 2 | 6934364 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 1335956 | ||
| Pubmed | 8.84e-05 | 152 | 102 | 5 | 34299191 | ||
| Pubmed | ABCA12 SIPA1 KIF20A TAF6L YEATS2 SLC16A1 SETD5 SSX2IP MACF1 CRYBG3 SIPA1L2 SLC4A11 | 1.07e-04 | 1116 | 102 | 12 | 31753913 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 8188220 | ||
| Pubmed | Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. | 1.27e-04 | 6 | 102 | 2 | 24390345 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 26955760 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 20676133 | ||
| Pubmed | Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. | 1.27e-04 | 6 | 102 | 2 | 20081857 | |
| Pubmed | 1.30e-04 | 263 | 102 | 6 | 34702444 | ||
| Pubmed | 1.60e-04 | 92 | 102 | 4 | 23055941 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 17875931 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 37315142 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 12915301 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 14757526 | ||
| Pubmed | 1.88e-04 | 96 | 102 | 4 | 17971504 | ||
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 24413532 | ||
| Pubmed | Upg-2: a urinary pepsinogen variant located on chromosome 1 of the mouse. | 2.36e-04 | 8 | 102 | 2 | 7165695 | |
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 1981051 | ||
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 24036464 | ||
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 10331952 | ||
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 20622009 | ||
| Pubmed | A genetic map of mouse chromosome 1 near the Lsh-Ity-Bcg disease resistance locus. | 2.36e-04 | 8 | 102 | 2 | 1970800 | |
| Pubmed | Linkage of genes for laminin B1 and B2 subunits on chromosome 1 in mouse. | 2.36e-04 | 8 | 102 | 2 | 2993224 | |
| Pubmed | 2.36e-04 | 8 | 102 | 2 | 31143101 | ||
| Pubmed | 2.47e-04 | 103 | 102 | 4 | 10574462 | ||
| Pubmed | Prevalence of common disease-associated variants in Asian Indians. | 3.03e-04 | 9 | 102 | 2 | 18248681 | |
| Pubmed | 3.04e-04 | 730 | 102 | 9 | 34857952 | ||
| Pubmed | 3.62e-04 | 47 | 102 | 3 | 15172686 | ||
| Pubmed | 3.72e-04 | 320 | 102 | 6 | 28685749 | ||
| Pubmed | 3.77e-04 | 10 | 102 | 2 | 27624071 | ||
| Pubmed | 3.77e-04 | 10 | 102 | 2 | 30127721 | ||
| Pubmed | 3.77e-04 | 10 | 102 | 2 | 3384439 | ||
| Pubmed | 3.77e-04 | 10 | 102 | 2 | 3416634 | ||
| Pubmed | 3.77e-04 | 10 | 102 | 2 | 38713721 | ||
| Pubmed | 4.14e-04 | 212 | 102 | 5 | 19521566 | ||
| Pubmed | 4.60e-04 | 11 | 102 | 2 | 20170731 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.84e-04 | 123 | 102 | 4 | 26912792 | |
| Pubmed | TRIO NACA POR TAB3 TENM4 SLC16A1 TENM1 MACF1 AK1 CRYBG3 SIPA1L2 | 5.20e-04 | 1139 | 102 | 11 | 36417873 | |
| Pubmed | 5.42e-04 | 225 | 102 | 5 | 12168954 | ||
| Pubmed | 5.51e-04 | 12 | 102 | 2 | 15140878 | ||
| Pubmed | 5.51e-04 | 12 | 102 | 2 | 32414917 | ||
| Pubmed | Cell autonomous roles of Nedd4 in craniofacial bone formation. | 5.51e-04 | 12 | 102 | 2 | 26681395 | |
| Pubmed | 5.51e-04 | 12 | 102 | 2 | 24080509 | ||
| Pubmed | 5.51e-04 | 12 | 102 | 2 | 21873549 | ||
| Pubmed | The CEP19-RABL2 GTPase Complex Binds IFT-B to Initiate Intraflagellar Transport at the Ciliary Base. | 5.51e-04 | 12 | 102 | 2 | 28625565 | |
| Pubmed | 5.51e-04 | 12 | 102 | 2 | 1358796 | ||
| Pubmed | 5.70e-04 | 634 | 102 | 8 | 34591612 | ||
| Pubmed | 6.50e-04 | 13 | 102 | 2 | 20301593 | ||
| Pubmed | 6.50e-04 | 13 | 102 | 2 | 25285789 | ||
| Pubmed | 6.50e-04 | 13 | 102 | 2 | 23393595 | ||
| Pubmed | 6.50e-04 | 13 | 102 | 2 | 18846501 | ||
| Pubmed | 6.50e-04 | 13 | 102 | 2 | 25648896 | ||
| Pubmed | 8.72e-04 | 15 | 102 | 2 | 24469813 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 9.24e-04 | 853 | 102 | 9 | 28718761 | |
| Pubmed | 9.64e-04 | 529 | 102 | 7 | 14621295 | ||
| Pubmed | 9.80e-04 | 66 | 102 | 3 | 23472066 | ||
| Pubmed | New loci associated with kidney function and chronic kidney disease. | 9.80e-04 | 66 | 102 | 3 | 20383146 | |
| Pubmed | 9.95e-04 | 16 | 102 | 2 | 28199315 | ||
| Pubmed | Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. | 9.95e-04 | 16 | 102 | 2 | 19487454 | |
| Pubmed | 9.95e-04 | 16 | 102 | 2 | 19948886 | ||
| Pubmed | 9.95e-04 | 16 | 102 | 2 | 15831516 | ||
| Pubmed | 1.13e-03 | 17 | 102 | 2 | 11683995 | ||
| Interaction | SIPA1 interactions | 1.60e-06 | 41 | 98 | 5 | int:SIPA1 | |
| Interaction | PFN1 interactions | CAND1 HDAC5 TRIO VPS13C ESR1 INPPL1 ADAM10 NEDD4 MACF1 CRYBG3 SIPA1L2 DNMBP | 6.70e-06 | 509 | 98 | 12 | int:PFN1 |
| Cytoband | 8p23.1 | 4.01e-04 | 154 | 102 | 4 | 8p23.1 | |
| Cytoband | 7q31.3 | 5.04e-04 | 15 | 102 | 2 | 7q31.3 | |
| GeneFamily | RAB like GTPases | 1.42e-04 | 5 | 69 | 2 | 394 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN | 9.44e-06 | 199 | 97 | 7 | M5240 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 160 | 101 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 160 | 101 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-06 | 181 | 101 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.60e-06 | 181 | 101 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 184 | 101 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 184 | 101 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 184 | 101 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 4.48e-06 | 188 | 101 | 6 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.52e-06 | 195 | 101 | 6 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.52e-06 | 195 | 101 | 6 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.52e-06 | 195 | 101 | 6 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, condition lineage and cell class | 6.21e-06 | 199 | 101 | 6 | 1b17e6d5e6b994dec65efae2667f4f1f438161b1 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 9.04e-06 | 123 | 101 | 5 | 967f20fcb27c9989de93f4183038334105910175 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-05 | 147 | 101 | 5 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 155 | 101 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 155 | 101 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 161 | 101 | 5 | da9eecf919866a9c579d7a707a996cf335213134 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 161 | 101 | 5 | d431625c32f59a6b552191f3adc5198bd16ad5cf | |
| ToppCell | facs-GAT-Fat-24m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 173 | 101 | 5 | 815ba48a9222ea09ba8005e2d2f7c5addf118ad1 | |
| ToppCell | facs-GAT-Fat-24m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 173 | 101 | 5 | 98e464d9e6d6b69421e9e4041b638b6825247f60 | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.66e-05 | 173 | 101 | 5 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | facs-GAT-Fat-24m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 173 | 101 | 5 | 3e6f0a08eddfd61871f7a85acccf6d539af6ebda | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 176 | 101 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.48e-05 | 179 | 101 | 5 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.25e-05 | 184 | 101 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 6.41e-05 | 185 | 101 | 5 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-05 | 185 | 101 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-05 | 185 | 101 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.57e-05 | 186 | 101 | 5 | 107bc473f5e57238390f8e0ab9f7263a8f93948c | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.57e-05 | 186 | 101 | 5 | 13a9ddcf93b0c4319ab9d484af5e2056e9754caa | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 6.91e-05 | 188 | 101 | 5 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-05 | 188 | 101 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 7.09e-05 | 189 | 101 | 5 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | mild_COVID-19-Platelet|World / disease group, cell group and cell class (v2) | 7.09e-05 | 189 | 101 | 5 | 038ec3c266b89416bb5b774ba522d916394961da | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.09e-05 | 189 | 101 | 5 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.09e-05 | 189 | 101 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.45e-05 | 191 | 101 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 191 | 101 | 5 | d78d4fbb0b8317dbf14e32182466a432abef3e93 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.64e-05 | 192 | 101 | 5 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.82e-05 | 193 | 101 | 5 | c3522693439c23830d8a3f20854539ccb7a666e0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.21e-05 | 195 | 101 | 5 | 32ec72103faccc9e37c0ecedff1998e7df6a19f6 | |
| ToppCell | severe-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.21e-05 | 195 | 101 | 5 | 43ff1eed563c647bc5b7b06ffe136210653c3a83 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 196 | 101 | 5 | a37ba02446eef5d1fab703204583f6550a8ec3e1 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 196 | 101 | 5 | a156840330630e518bc85633dded6f2c3ead3b30 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 196 | 101 | 5 | 89ea4d2086e1c769c5a87f1471a6cd4acabcfe33 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.41e-05 | 196 | 101 | 5 | 37a5f9f3988778655580bd0383811bb4930c1551 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 8.62e-05 | 197 | 101 | 5 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | control-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.62e-05 | 197 | 101 | 5 | cdb2866d5a8fbf39847309124479ad49c88852d4 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 8.83e-05 | 198 | 101 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | mild-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.83e-05 | 198 | 101 | 5 | ba97ff6e9d400b53ad013dce54afd7154a0f4fc9 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 199 | 101 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 9.04e-05 | 199 | 101 | 5 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 9.25e-05 | 200 | 101 | 5 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.25e-05 | 200 | 101 | 5 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 02594c1edbc9f2cf831639cd83363abd2551cb94 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.25e-05 | 200 | 101 | 5 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 46521d83b917b0357601db8783c8da6b73730d60 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 9.25e-05 | 200 | 101 | 5 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 9.25e-05 | 200 | 101 | 5 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.25e-05 | 200 | 101 | 5 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-04 | 113 | 101 | 4 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.55e-04 | 46 | 101 | 3 | 37ea73d291e35b6865bd3ea4857275a6e5b299d1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Nefl_(Neurofilament_state)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.55e-04 | 46 | 101 | 3 | 69e9c8cbae3d15bd0823b8c6e48a9d2b9815296b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-04 | 124 | 101 | 4 | 298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 127 | 101 | 4 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.15e-04 | 143 | 101 | 4 | 8f897278f9ccc82ae35e4f30c5f930b2a3eb509d | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis_(SGZ)_(Ppp2r2b))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.60e-04 | 61 | 101 | 3 | f470e0a6b3d5062e71635d643bce15f85ffda8ab | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.77e-04 | 62 | 101 | 3 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.77e-04 | 62 | 101 | 3 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 3.96e-04 | 152 | 101 | 4 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | IIH-CD8-exh_CD4|IIH / Condition, Cell_class and T cell subcluster | 4.16e-04 | 154 | 101 | 4 | a2f51a3c5455fe2483e438375ea856afce8262fe | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-04 | 154 | 101 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.16e-04 | 154 | 101 | 4 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-04 | 154 | 101 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.27e-04 | 155 | 101 | 4 | 29c4e9947bb4f7e257ed5c3bcf21bd67f88d473f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.27e-04 | 155 | 101 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-04 | 156 | 101 | 4 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-04 | 156 | 101 | 4 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-04 | 157 | 101 | 4 | dd08dc19d434e94a194076c462ee273c682abf55 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.48e-04 | 157 | 101 | 4 | 70fd6c46db4250c7de5c4686a9500689402737f6 | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 4.59e-04 | 158 | 101 | 4 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.59e-04 | 158 | 101 | 4 | 1635a85fc73c544028418087f36d28957dd4f458 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-04 | 158 | 101 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.59e-04 | 158 | 101 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.59e-04 | 158 | 101 | 4 | 80841dadfa53bcde36a3e486408a095f78e772eb | |
| ToppCell | Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, Lineage and Cell Type | 4.59e-04 | 158 | 101 | 4 | 05a29c2d5506a25ccdfa4c6a86e9188977a18272 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.59e-04 | 158 | 101 | 4 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.59e-04 | 158 | 101 | 4 | 1bf692f1e85f677cd62805437b7a59cfaf3b0449 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.81e-04 | 160 | 101 | 4 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | CV-Mild-4|CV / Virus stimulation, Condition and Cluster | 4.81e-04 | 160 | 101 | 4 | be89efeeecb0de96ce136a7a62738f15dc0badb2 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 161 | 101 | 4 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 161 | 101 | 4 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | 15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 5.04e-04 | 162 | 101 | 4 | e190c496ed1e206b86566edfee23c99a99fe90d0 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-04 | 163 | 101 | 4 | a1fbefe53523a9879a4d4b493071059798b5f917 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-04 | 163 | 101 | 4 | 454a5e87e2f9f66e38cc5aa1b433c47b54c9be42 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-04 | 163 | 101 | 4 | d9bd9d90cfa4e85d5ea51f8f3ee14a700571f508 | |
| ToppCell | 5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-04 | 163 | 101 | 4 | f6847f47a8856c0d4136c1af317432d45eccfde9 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.16e-04 | 163 | 101 | 4 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | 5'-Airway_Nasal_SMG|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-04 | 163 | 101 | 4 | d8450bf9c6d2ec5dd1472952c9e65f82f995337a | |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; HL60; HG-U133A | 1.96e-06 | 196 | 97 | 8 | 1990_UP | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 5.61e-06 | 160 | 97 | 7 | 6133_DN | |
| Disease | Depression, Bipolar | 4.70e-06 | 79 | 91 | 5 | C0005587 | |
| Disease | FVC change measurement, response to placebo | 7.94e-06 | 13 | 91 | 3 | EFO_0008344, EFO_0010339 | |
| Disease | Bipolar Disorder | 1.70e-05 | 477 | 91 | 9 | C0005586 | |
| Disease | Autosomal Dominant Lateral Temporal Lobe Epilepsy | 2.82e-05 | 3 | 91 | 2 | C1838062 | |
| Disease | Ichthyosis Congenita I | 5.62e-05 | 4 | 91 | 2 | C4551630 | |
| Disease | Harlequin Fetus | 5.62e-05 | 4 | 91 | 2 | C0239849 | |
| Disease | beta-defensin 104 measurement | 5.62e-05 | 4 | 91 | 2 | EFO_0801416 | |
| Disease | Ichthyosis Congenita II | 5.62e-05 | 4 | 91 | 2 | C3536797 | |
| Disease | leukemia inhibitory factor measurement | 5.62e-05 | 4 | 91 | 2 | EFO_0801764 | |
| Disease | autosomal recessive congenital ichthyosis 1 (is_implicated_in) | 5.62e-05 | 4 | 91 | 2 | DOID:0060656 (is_implicated_in) | |
| Disease | Collodion Fetus | 5.62e-05 | 4 | 91 | 2 | C3543867 | |
| Disease | Manic Disorder | 7.02e-05 | 71 | 91 | 4 | C0024713 | |
| Disease | C-reactive protein measurement | UBR2 TCF7L2 OR9G1 GLS2 MFHAS1 IFT172 VPS13C CCDC168 OR9G9 ACOD1 YEATS2 SETD5 MACF1 | 8.26e-05 | 1206 | 91 | 13 | EFO_0004458 |
| Disease | Congenital ichthyosis | 9.35e-05 | 5 | 91 | 2 | C0020758 | |
| Disease | Manic | 1.01e-04 | 78 | 91 | 4 | C0338831 | |
| Disease | Stage IV Skin Melanoma | 1.96e-04 | 7 | 91 | 2 | C1321872 | |
| Disease | Neonatal sepsis | 2.60e-04 | 8 | 91 | 2 | HP_0040187 | |
| Disease | age at diagnosis, osteonecrosis | 3.43e-04 | 44 | 91 | 3 | EFO_0004259, EFO_0004918 | |
| Disease | Fuchs endothelial corneal dystrophy | 4.17e-04 | 10 | 91 | 2 | Orphanet_98974 | |
| Disease | depressive disorder (is_marker_for) | 4.17e-04 | 10 | 91 | 2 | DOID:1596 (is_marker_for) | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 5.08e-04 | 11 | 91 | 2 | C0079154 | |
| Disease | Congenital ichthyosis of skin | 5.08e-04 | 11 | 91 | 2 | cv:C0020758 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 6.08e-04 | 12 | 91 | 2 | DOID:3319 (is_marker_for) | |
| Disease | bitter alcoholic beverage consumption measurement | 7.79e-04 | 133 | 91 | 4 | EFO_0010092 | |
| Disease | creatinine measurement | CFH VIL1 TCF7L2 CAND1 PDE7A SIPA1L3 POR ADGRV1 PLXNB2 PIP5K1B | 9.89e-04 | 995 | 91 | 10 | EFO_0004518 |
| Disease | Congenital total cataract | 1.10e-03 | 16 | 91 | 2 | C0266539 | |
| Disease | Mental Depression | 1.16e-03 | 254 | 91 | 5 | C0011570 | |
| Disease | Psychoses, Substance-Induced | 1.24e-03 | 17 | 91 | 2 | C0033941 | |
| Disease | smoking status measurement, systolic blood pressure | 1.41e-03 | 156 | 91 | 4 | EFO_0006335, EFO_0006527 | |
| Disease | brain connectivity measurement | 1.51e-03 | 400 | 91 | 6 | EFO_0005210 | |
| Disease | sucrose liking measurement | 1.72e-03 | 20 | 91 | 2 | EFO_0010157 | |
| Disease | Mood Disorders | 1.84e-03 | 168 | 91 | 4 | C0525045 | |
| Disease | Psychoses, Drug | 1.90e-03 | 21 | 91 | 2 | C0033937 | |
| Disease | Ovarian Failure, Premature | 1.90e-03 | 21 | 91 | 2 | C0085215 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.97e-03 | 171 | 91 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | Depressive disorder | 2.04e-03 | 289 | 91 | 5 | C0011581 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 2.48e-03 | 24 | 91 | 2 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | pseudotumor cerebri | 2.91e-03 | 26 | 91 | 2 | EFO_1001132 | |
| Disease | L lactate dehydrogenase measurement | 2.91e-03 | 26 | 91 | 2 | EFO_0004808 | |
| Disease | myeloperoxidase measurement | 2.91e-03 | 26 | 91 | 2 | EFO_0005243 | |
| Disease | Neurodevelopmental Disorders | 3.01e-03 | 93 | 91 | 3 | C1535926 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 3.01e-03 | 93 | 91 | 3 | DOID:3525 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSYLHGDYVQSTSQL | 311 | Q8NEC5 | |
| TSKLHSSLKSAYHQY | 2226 | Q68DQ2 | |
| SSLKSAYHQYLQTSQ | 2231 | Q68DQ2 | |
| AVYSSGSERHLTYIQ | 131 | O15254 | |
| SNKVLDYDTSHIYTG | 91 | O14672 | |
| YSGCSLSYTNSHVEK | 596 | Q9Y2D8 | |
| SYLTTKEHLLLYGSI | 1431 | Q86UK0 | |
| LVYTYNETGSLHSVS | 71 | Q9Y3Q7 | |
| TKYAEIYGISSAHTL | 706 | Q9UDR5 | |
| LSLHYKTLGSNATYI | 1396 | Q8WXG9 | |
| NLASYTKKHHTSSVY | 501 | Q6XZF7 | |
| NLSLKYSQTGYLSSS | 551 | Q5W041 | |
| SSQESYAHGTKLSYT | 886 | P08603 | |
| YTSVYSHTTRNSAGK | 116 | P60323 | |
| TKSINISDYSPYGTH | 906 | Q5TC82 | |
| SSHLTSVTLYYGSIL | 241 | Q8NH87 | |
| YSYSKIISSIHAISS | 216 | Q15622 | |
| LSTYALTLYKHTATV | 51 | Q9UBK7 | |
| LSTYALTLYKHTATV | 51 | Q9UNT1 | |
| HQYEVSSSLGYTSTR | 541 | O75140 | |
| LVFLSSYGKSQHYSS | 281 | P53985 | |
| SHSYVLVTSLNLSYD | 286 | P43364 | |
| TLLSKGSYQTSHQFI | 286 | P46934 | |
| LQARYYSIASSSKVH | 451 | P16435 | |
| QSALSYLHESGKLLY | 701 | Q9Y4C4 | |
| IYHSGSTNYNPSLKS | 71 | A0A075B6R2 | |
| KYGYTHLSTGDLLRS | 31 | P00568 | |
| IYTSVLKHSGSYTSV | 6256 | Q5CZC0 | |
| QSTALTHKQSYYSIA | 786 | Q86VP6 | |
| TDHATYKAGYLSTNT | 201 | O15031 | |
| AGSTSSHSLQKYYIT | 571 | P03372 | |
| GSTIPYQYKHITTCS | 8356 | Q7Z5P9 | |
| YLTLQEHYSSLKGLT | 176 | P00480 | |
| KTNHYLATLYKNTSV | 266 | Q13946 | |
| ATTISSSSLYVNEHY | 476 | O14986 | |
| NYSRGSTVHTAYLVL | 16 | Q8TDS7 | |
| LQKDSSKIYTTHISY | 131 | Q6ZMV9 | |
| YKTVTISDHGTVTYN | 61 | P13473 | |
| YAISISTLGTDYVHK | 226 | Q9UI32 | |
| GYTYQHISRDLSATV | 186 | Q05C16 | |
| SYIKISNSSHSEYSS | 586 | Q9ULI3 | |
| NLSSSDSPYHYTKVT | 726 | P0C869 | |
| ISTTTHYNRIGTKYN | 461 | P23471 | |
| SSHLTSVTLYYGSIL | 241 | P0C7N8 | |
| RLGYTHLYSSTQVSV | 396 | P39656 | |
| SHSHVGYTLSYKAQS | 61 | Q96JZ2 | |
| HTSYAETLGKLETQY | 651 | Q9UPN3 | |
| HITLDTLSYSSYKVP | 506 | P78509 | |
| LYITKVTTTHVGNYT | 306 | Q8N475 | |
| LSSGTRVVLKSHYGY | 341 | Q9UG01 | |
| YQSGFKSIHDSLSSL | 406 | Q96LP2 | |
| ACTISKDHGYTIYST | 186 | P08908 | |
| HLYSSTTVLKYQKGN | 171 | Q8IY82 | |
| HIASQYSKIYSSNIS | 51 | A6NK06 | |
| KKAYTESLHGYTLSN | 4986 | Q8NDH2 | |
| NSHGETVKTLYLSYL | 446 | Q5T890 | |
| QTVHSEYHTLLYGTS | 741 | Q9UQL6 | |
| LASHLYTTYRLGKTV | 71 | Q7RTR8 | |
| SSLTDDLLKYYHQVT | 151 | Q9Y6J9 | |
| YLDDYHTKRTSSLVS | 506 | Q8NBS3 | |
| YSKSLDRHLYTTTGG | 386 | Q99523 | |
| GTGKSYVSSLLAHYL | 96 | Q8N2E6 | |
| HSVAYLPYTASSLSK | 346 | Q8N5C8 | |
| YGHTASGKTYVTQTL | 36 | O43913 | |
| SSYKHNGTELTLRYS | 136 | P00797 | |
| QVTYSLHLYSVNGKL | 2626 | Q6ZNJ1 | |
| HGISRTLTLVESNYY | 86 | Q9NXP7 | |
| SVASYILASHNGISY | 66 | Q8NEK8 | |
| TDSTGTHSLYTTYKD | 661 | Q9P2F8 | |
| AKLYSVHGYASTISA | 1311 | Q9P2F8 | |
| KTDSTGTHSLYTMYQ | 676 | O60292 | |
| NGLSTVSHDYLKGSY | 176 | O15357 | |
| EKSVYSTHNYGTTQR | 36 | Q9C0A6 | |
| KTDSTGTHSLYTTYQ | 386 | Q96FS4 | |
| THLYNHTSSEITSLY | 2281 | Q9UKZ4 | |
| GTGKSYVSSLLAHYL | 96 | Q5JU69 | |
| YIILAIHKTASSLSY | 46 | P09327 | |
| SHLVSLGYQISKSYI | 41 | Q6ZN79 | |
| SSTLTYYKSIHTGEK | 181 | Q8N7Q3 | |
| YYSRSKTTHIIATNL | 81 | Q9UBZ9 | |
| IYTYGVTNSGKTHTI | 156 | O95235 | |
| SQKSYLTVHYRTHSG | 661 | Q9NYW8 | |
| QSGSTHYSAYKTIEH | 131 | Q9NQB0 | |
| THRKYYSTTHGALLS | 521 | Q9NWM0 | |
| SQIAYTSLSLPHYGS | 376 | P56693 | |
| SLSHLKSSITNYFGA | 531 | Q5T6S3 | |
| LYLFDTTGKHLYTQS | 1586 | Q6N022 | |
| SSEITSLYYDLQGHL | 2331 | Q6N022 | |
| GILEHQYKESTTYIS | 2596 | Q709C8 | |
| KTTQLTQYLHEDGYT | 561 | Q92620 | |
| HLEANTSTLYYLVSG | 2961 | Q86WI1 | |
| SHLVSLGYQISKSYI | 41 | A8MWA4 | |
| SHLVSLGYQISKSYI | 41 | A8MUZ8 | |
| SHLVSLGYQISKSYI | 41 | P0CI00 | |
| SHLVSLGYQISKSYI | 41 | P0CH99 | |
| TSSSGHYISDVYDIK | 901 | Q86T82 | |
| SYTSKYNLVTHILGH | 261 | Q8N895 | |
| KLHLYLSVTFYTGVS | 611 | P22735 | |
| ALSLNSLHTVRYYSK | 356 | Q9NX45 | |
| LALYKTLHQYTGSAL | 1481 | Q8IWV8 | |
| HYKKLYVSRGSASTS | 211 | Q99990 | |
| HYSISYSDLGEATLK | 2731 | O75962 | |
| GGISQHLTYTSYILK | 841 | Q9ULM3 | |
| RLSTANTYSYHKVDL | 96 | Q96S16 | |
| LQKSLSSYNYIHVGA | 221 | O94832 | |
| SSYNYIHVGAQLKSS | 226 | O94832 | |
| TSLILKSSPNATYHY | 411 | E9PAV3 |